- Home
- RYAM vs NPCE Comparison
RYAM vs NPCE Comparison
Compare RYAM & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RYAM | NPCE |
|---|---|---|
| Founded | 1926 | 1997 |
| Country | United States | United States |
| Employees | 2325 | N/A |
| Industry | Paper | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 491.8M | 485.6M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RYAM | NPCE |
|---|---|---|
| Price | $11.03 | $14.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $14.00 | ★ $18.33 |
| AVG Volume (30 Days) | ★ 1.1M | 182.2K |
| Earning Date | 06-01-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,466,397,000.00 | $99,986,000.00 |
| Revenue This Year | $5.46 | $25.95 |
| Revenue Next Year | $8.02 | $0.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $3.35 | $7.56 |
| 52 Week High | $11.05 | $18.97 |
Technical Indicators
Market Signals| Indicator | RYAM | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 66.86 | 44.82 |
| Support Level | $7.09 | $14.02 |
| Resistance Level | N/A | $16.96 |
| Average True Range (ATR) | 0.74 | 0.74 |
| MACD | 0.18 | 0.00 |
| Stochastic Oscillator | 94.90 | 55.38 |
Price Performance
Historical ComparisonAbout RYAM Rayonier Advanced Materials Inc.
Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.